CAFI CONSUMER AUTOMOTIVE FIN INC

Consumer Automotive Finance, Inc. (OTC: CAFI) Files Form 15c2-11 to Enhance Transparency and Compliance

Consumer Automotive Finance, Inc. (OTC: CAFI) Files Form 15c2-11 to Enhance Transparency and Compliance

Company Announces Pending Name and Ticker Symbol Change to Fifty 1 Labs, Inc. (OTC: FITY)

MELBOURNE, Fla., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Consumer Automotive Finance, Inc. (), a diversified company operating in the sports supplement, fitness equipment, and health and wellness industries, is pleased to announce two key developments in its corporate evolution:

Filing of Form 15c2-11 to Enhance Transparency and Compliance:

The company has filed Form 15c2-11 with the U.S. Securities and Exchange Commission (SEC), marking a significant step toward improving its financial transparency and compliance. This filing is required by the SEC to enable a company to maintain its quotation on the Over-the-Counter (OTC) Markets. By meeting these regulatory standards, Consumer Automotive Finance, Inc. aims to provide accurate, complete, and timely financial information to the public.

The filing aligns with the company's ongoing commitment to improving shareholder communication and corporate governance. It ensures that investors, analysts, and regulators have clear insights into the company's financial health, operations, and strategic direction.

"We are excited to take this step towards enhancing our corporate governance and financial transparency," said Robert Clark, CEO of Consumer Automotive Finance, Inc. "Filing Form 15c2-11 reflects our commitment to building long-term value for our shareholders and ensuring that we adhere to the highest standards of regulatory compliance. This move will provide greater clarity and confidence to our investors as we continue to grow our business and expand into new markets."

Pending Name and Ticker Symbol Change to Fifty 1 Labs, Inc. (OTC: FITY):

As part of its long-term strategy, Consumer Automotive Finance, Inc. is finalizing a strategic rebranding, which includes a corporate name change to Fifty 1 Labs, Inc. and a new ticker symbol, FITY. This rebranding reflects the company's expanded focus on innovation in health, fitness, and wellness.

The name change accompanies the launch of the company's "51" sports supplement brand, featuring pre-workout and BCAA products, as well as its subsidiaries specializing in wellness solutions, athletic equipment, and anti-aging products.

"The name change to Fifty 1 Labs, Inc. symbolizes a new chapter in our company's transformation," added Clark. "This rebranding reflects our dedication to delivering cutting-edge solutions and creating value for our shareholders."

About Fifty 1 Labs, Inc.

Consumer Automotive Finance, Inc. (OTCPK: CAFI), soon to be renamed Fifty 1 Labs, Inc., is a publicly traded company focused on sports supplementation, fitness equipment, and holistic wellness. The company operates four key subsidiaries: 51, LLC, which specializes in sports supplements; The Quickness, which offers patented athletic training equipment; Astound NMN, a leader in anti-aging and DNA repair supplements; and Drago Knives, patented knife throwing technology. Fifty 1 Labs, Inc. is also actively pursuing strategic acquisitions to expand its portfolio and drive sustainable growth.

Safe Harbor Statement:

The information provided in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Identifiable by words such as "may," "will," "should," "plans," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions, these statements may also be made in written or oral form in the company's filings with the U.S. Securities and Exchange Commission, OTC Markets, press releases, other written materials, or in oral statements made by its officers, directors, or employees to third parties. There can be no assurance that such statements will prove to be accurate. The company cautions that these forward-looking statements are further qualified by other factors including, but not limited to, those set forth in the company's Disclosure Statements. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, and various other factors beyond the company's control. The company does not undertake any obligation to update publicly or to revise any statements in this release, whether as a result of new information, future events, or otherwise.

Investor Relations Contact:

Investor Relations

844-714-2224



EN
09/12/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CONSUMER AUTOMOTIVE FIN INC

 PRESS RELEASE

Fifty1 Labs, Inc. Clarifies Status Regarding Previously Announced Coll...

Fifty1 Labs, Inc. Clarifies Status Regarding Previously Announced Collaboration with LUNR Aerospace VANCOUVER, British Columbia, Jan. 05, 2026 (GLOBE NEWSWIRE) -- via IBN -- Fifty1 Labs, Inc. (OTC:) today issues the following clarification regarding its press release dated August 26, 2025, which referenced a potential collaboration with LUNR Aerospace. It is the intent of this press release to clarify and confirm that no formal partnership or collaboration has ever been formed between Fifty1 Labs, Inc. (or its subsidiary Fifty1 AI Labs) and LUNR Aerospace and there is no current intent to...

 PRESS RELEASE

Fifty 1 Labs Inc. Appoints Dr. Joel Gagnier as Chief Science Officer

Fifty 1 Labs Inc. Appoints Dr. Joel Gagnier as Chief Science Officer Pioneering Evidence-Based AI Innovation in Personalized Wellness and Health Research VANCOUVER, British Columbia, Oct. 09, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty1 AI Labs, a subsidiary of Fifty1 Labs, Inc. (OTC: ) and a cutting-edge innovator at the intersection of AI, clinical research, and personalized wellness, today announced the appointment of Dr. Joel Gagnier, BA, ND, MSc, PhD, as Chief Science Officer (CSO). This strategic leadership addition underscores Fifty1 AI Labs' commitment to rigorous scientific stand...

 PRESS RELEASE

Fifty 1 Labs Inc. Signs Letter of Intent to Acquire BioSpark AI Techno...

Fifty 1 Labs Inc. Signs Letter of Intent to Acquire BioSpark AI Technologies Inc. Strategic Acquisition Bolsters AI-Driven Healthcare Innovation, Positioning Fifty 1 Labs as a Leader in Clinical Data Analytics VANCOUVER, British Columbia, Sept. 30, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 Labs Inc. (OTC: ), a leader in AI-powered healthcare and biotechnology solutions, is excited to announce the signing of a Letter of Intent (LOI) to acquire BioSpark AI Technologies Inc., a Vancouver-based innovator specializing in patented artificial intelligence systems for clinical data extraction...

 PRESS RELEASE

Fifty 1 Labs, Inc. Engages PCAOB Auditing Firm to Prepare for Uplist t...

Fifty 1 Labs, Inc. Engages PCAOB Auditing Firm to Prepare for Uplist to OTCQB Fifty 1 Labs continues to advance its portfolio of biotech and wellness initiatives VANCOUVER, British Columbia, Sept. 23, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 Labs, Inc, () a Nevada-based holding company revolutionizing health, wellness, and biotech through AI-driven drug repurposing and functional medicine, today announced that it has signed a letter of engagement with a Public Company Accounting Oversight Board (PCAOB) registered auditing firm. The engagement covers audits of the Company's 2024 and 2...

 PRESS RELEASE

Fifty1 Labs, Inc. Leadership Publishes Landmark Framework to Unlock Gl...

Fifty1 Labs, Inc. Leadership Publishes Landmark Framework to Unlock Global Oncology Data Through AI-Driven Real-World Evidence Leadership Team's Technical Primer Enhances Real-World Evidence (RWE) for Cross-Border Impact, Positioning Fifty1 AI Labs in a $48B Market Opportunity VANCOUVER, British Columbia, Sept. 04, 2025 (GLOBE NEWSWIRE) -- via IBN – Fifty1 AI Labs, a subsidiary of Fifty1 Labs, Inc. (OTC: ), announces the publication of a landmark technical primer on "transportability" methods in oncology real-world evidence (RWE). Authored by CTO Alind Gupta and CEO Paul Arora, the prim...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch